Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This Chinese Herbal Medicine (CHM) formulation is a proprietary blend of six herbs developed by researchers at Hong Kong Baptist University for the management of Type 2 Diabetes Mellitus (T2DM) and Metabolic Syndrome. Administered as oral granules, the treatment is designed to improve glycemic control, reduce blood pressure, and optimize lipid profiles. It is currently undergoing clinical evaluation in a pilot study to assess its feasibility, safety, and effectiveness in patients with comorbid T2DM and metabolic syndrome. The formulation is intended to provide a multi-target therapeutic approach to metabolic dysfunction, addressing both glucose metabolism and cardiovascular risk factors associated with metabolic syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chinese Herbal Medicine granules (HKBU).